Abstract
The discovery of new treatments for cancer is an ongoing challenge. Data from the IARC (WHO) and the INCA (Ministry of Health) show breast tumors as the dominant cause of mortality among women affected by cancer. Tamoxifen is one of the main antineoplastic drug used against breast cancer. Although it is well tolerated, tamoxifen causes adverse effects that are similar to the symptoms of m…